| Secondary |
| Schizophrenia |
46.1% |
| Drug Exposure During Pregnancy |
11.6% |
| Anxiety |
8.5% |
| Insomnia |
7.7% |
| Product Used For Unknown Indication |
6.4% |
| Drug Use For Unknown Indication |
2.6% |
| Bipolar Disorder |
2.3% |
| Diabetes Mellitus |
2.0% |
| Alcoholic Psychosis |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Iron Deficiency Anaemia |
1.6% |
| Prophylaxis |
1.5% |
| Depression |
1.3% |
| Hallucination, Auditory |
1.1% |
| Constipation |
0.8% |
| Antidepressant Therapy |
0.7% |
| Asocial Behaviour |
0.7% |
| Back Pain |
0.7% |
| Delusion |
0.7% |
| Neurosis |
0.7% |
|
| Psychiatric Symptom |
16.4% |
| Irritability |
13.4% |
| Paroxysmal Perceptual Alteration |
9.0% |
| Ileus |
7.5% |
| Pneumonia |
7.5% |
| Ill-defined Disorder |
4.5% |
| Pulmonary Embolism |
4.5% |
| Tachypnoea |
4.5% |
| Dissociation |
3.0% |
| Drug Withdrawal Syndrome Neonatal |
3.0% |
| Granulocyte Count Decreased |
3.0% |
| Iritis |
3.0% |
| Pneumonia Aspiration |
3.0% |
| Renal Impairment |
3.0% |
| Suicide Attempt |
3.0% |
| Urinary Tract Infection |
3.0% |
| Uterine Leiomyoma |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Cardiac Hypertrophy |
1.5% |
| Jaundice |
1.5% |
|
| Concomitant |
| Schizophrenia |
22.6% |
| Prophylaxis |
16.4% |
| Insomnia |
6.9% |
| Depression |
6.4% |
| Constipation |
5.6% |
| Product Used For Unknown Indication |
5.6% |
| Acute Lymphocytic Leukaemia |
4.2% |
| Anxiety |
4.2% |
| Drug Use For Unknown Indication |
3.3% |
| Parkinsonism |
3.3% |
| Schizoaffective Disorder |
2.9% |
| Epilepsy |
2.7% |
| Hypertension |
2.3% |
| Hallucination |
2.1% |
| Schizophrenia, Paranoid Type |
2.1% |
| Agitation |
1.9% |
| Asthma |
1.9% |
| Hiv Infection |
1.9% |
| Sleep Disorder |
1.9% |
| Parkinson's Disease |
1.6% |
|
| Pancytopenia |
10.4% |
| Psychotic Disorder |
9.4% |
| White Blood Cell Count Decreased |
9.4% |
| Hepatic Function Abnormal |
7.3% |
| Paroxysmal Perceptual Alteration |
6.3% |
| Constipation |
5.2% |
| Rash |
5.2% |
| Gastric Ulcer Haemorrhage |
4.2% |
| Hyponatraemia |
4.2% |
| Renal Failure Acute |
4.2% |
| Shock |
4.2% |
| Somnolence |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Arterial Occlusive Disease |
3.1% |
| Cardiac Failure |
3.1% |
| Cardiac Failure Acute |
3.1% |
| Cerebral Haemorrhage |
3.1% |
| Cystitis Haemorrhagic |
3.1% |
| Liver Disorder |
3.1% |
| Muscular Weakness |
3.1% |
|
| Interacting |
| Delirium |
25.0% |
| C-reactive Protein Increased |
12.5% |
| Constipation |
12.5% |
| Gastritis |
12.5% |
| Pneumonia |
12.5% |
| Pyrexia |
12.5% |
| Urinary Tract Infection |
12.5% |
|
|
